Proceedings of the Final Congress of COST Action B25
Variability and Impact on Design of Bioequivalence Studies
Physiologically Based Modelling and Prediction of Drug Interactions
Predicting Drug Disposition via Application of a Biopharmaceutics Drug Disposition Classification System
Biopharmaceutical Classification Based on Solubility and Dissolution
Mode of Action Considerations in the Quantitative Assessment of Tumour Responses in the Liver
Modelling of Drug Disposition Kinetics in In Vitro Intestinal Absorption Cell Models
An Integrated Model for the Glucose-Insulin System
On Setting the First Dose in Man
Pharmacodynamic Effects of Haematopoietic Cytokines
Active-Site Concentrations of Chemicals – Are They a Better Predictor of Effect than Plasma/Organ/Tissue Concentrations?
The New European Medicines Agency Guideline on the Investigation of Bioequivalence
Sex Differences in Animal Models of Depression and Antidepressant Response
Model-Based Neutrophil-Guided Dose Adaptation in Chemotherapy
Pharmacodynamic Effects in the Cardiovascular System
Optimal Design of Pharmacokinetic Studies
Physiologically Based Pharmacokinetic/Pharmacodynamic Animal-to-Man Prediction of Therapeutic Dose in a Model of Epilepsy
Predictable and Less Predictable Unwanted Cardiac Drugs Effects